Literature DB >> 9513735

Frontal lobe of children with schizophrenia spectrum disorders: a proton magnetic resonance spectroscopic study.

W M Brooks1, J Hodde-Vargas, L A Vargas, R A Yeo, C C Ford, R L Hendren.   

Abstract

BACKGROUND: Schizophrenia is commonly considered a neurodevelopmental disorder. Our aim was to determine whether the proton magnetic resonance spectroscopic (1H-MRS) changes seen in adults with schizophrenia are displayed in children at risk for developing schizophrenia.
METHODS: Children with symptoms of schizophrenia-spectrum disorders (n = 16; mean age = 132 months) and a comparison group (n = 12; mean age 130 months) took part in a 1H-MRS study of the left frontal lobe. Areas of peaks from N-acetylaspartate (NAA), choline (Cho), and creatine (Cre) were determined and ratios of NAA/Cre and Cho/Cre calculated and compared between groups.
RESULTS: The mean ratio of NAA/Cre was significantly lower in schizophrenia-spectrum subjects than the comparison group (1.67 vs. 1.92; p < .05). Medication status did not affect results in schizophrenia-spectrum subjects.
CONCLUSIONS: Our findings suggest that the metabolic changes associated with adult schizophrenia are observed in children with some or all of the symptoms of schizophrenia, supporting a neurodevelopmental theory for schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9513735     DOI: 10.1016/S0006-3223(97)00462-9

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  6 in total

1.  Refractory symptomatic schizophrenia resulting from frontal lobe lesion: response to clozapine.

Authors:  J G Burke; S M Dursun; M A Reveley
Journal:  J Psychiatry Neurosci       Date:  1999-11       Impact factor: 6.186

2.  Proton magnetic resonance spectroscopy and thought disorder in childhood schizophrenia.

Authors:  Ronald R Seese; Joseph O'Neill; Matthew Hudkins; Prabha Siddarth; Jennifer Levitt; Ben Tseng; Keng Nei Wu; Rochelle Caplan
Journal:  Schizophr Res       Date:  2011-08-27       Impact factor: 4.939

3.  Reduced N-acetyl-aspartate levels in schizophrenia patients with a younger onset age: a single-voxel 1H spectroscopy study.

Authors:  Jeffrey A Stanley; Madhuri Vemulapalli; Jeffrey Nutche; Debra M Montrose; John A Sweeney; Jay W Pettegrew; Frank P MacMaster; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2007-05-10       Impact factor: 4.939

Review 4.  The neural effects of psychotropic medications in children and adolescents.

Authors:  Manpreet K Singh; Kiki D Chang
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2012-10

Review 5.  T2 relaxation effects on apparent N-acetylaspartate concentration in proton magnetic resonance studies of schizophrenia.

Authors:  Bethany K Bracken; Elizabeth D Rouse; Perry F Renshaw; David P Olson
Journal:  Psychiatry Res       Date:  2013-06-12       Impact factor: 3.222

6.  N-Acetyl-Aspartate Level is Decreased in the Prefrontal Cortex in Subjects At-Risk for Schizophrenia.

Authors:  Marine Mondino; Jerome Brunelin; Mohamed Saoud
Journal:  Front Psychiatry       Date:  2013-09-05       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.